in addition, the length of kiacta tm phase iii confirmatory study is dependent upon many factors including clinical sites activation, patients enrollment rate, patients drop out rate and occurrence of worsening events. consequently actual future results may differ materially from the anticipated results expressed in the forward looking statements.